BACKGROUND: Treatment of gastric cancer is based on accurate staging. Emerging methods, such as PET-CT, are increasingly being used for this purpose. Our aim was to analyze the results of EUS and PET-CT in staging and restaging our patients with gastric cancer, comparing both of them with the histological results. METHODS: Patients with confirmed gastric cancer were prospectively enrolled. Inclusion criteria for the final analysis included only patients who finally received a surgical resection. All patients underwent preoperative TNM staging by means of EUS and PET-CT within 21 days prior to the surgical treatment. RESULTS: A total of 256 patients were included. The overall EUS accuracy for T staging was 78% and 80.2% in restaging. EUS showed its best accuracy when distinguishing T1-T2 tumors vs. T3-T4, with an increased accuracy in restaging. Regarding N staging, the overall accuracy of EUS was 76.2%, and 72.5% for PET-CT (p = 0.02). With regards to restaging, accuracy of EUS and PET-CT for N staging was 88.5% and 69%, respectively, with significant differences (p < 0.0001). CONCLUSIONS: EUS performed better than PET-CT in gastric cancer N staging and restaging. EUS accuracy in this setting is still suboptimal and probably more than one single diagnostic procedure should be used.
BACKGROUND: Treatment of gastric cancer is based on accurate staging. Emerging methods, such as PET-CT, are increasingly being used for this purpose. Our aim was to analyze the results of EUS and PET-CT in staging and restaging our patients with gastric cancer, comparing both of them with the histological results. METHODS:Patients with confirmed gastric cancer were prospectively enrolled. Inclusion criteria for the final analysis included only patients who finally received a surgical resection. All patients underwent preoperative TNM staging by means of EUS and PET-CT within 21 days prior to the surgical treatment. RESULTS: A total of 256 patients were included. The overall EUS accuracy for T staging was 78% and 80.2% in restaging. EUS showed its best accuracy when distinguishing T1-T2 tumors vs. T3-T4, with an increased accuracy in restaging. Regarding N staging, the overall accuracy of EUS was 76.2%, and 72.5% for PET-CT (p = 0.02). With regards to restaging, accuracy of EUS and PET-CT for N staging was 88.5% and 69%, respectively, with significant differences (p < 0.0001). CONCLUSIONS: EUS performed better than PET-CT in gastric cancer N staging and restaging. EUS accuracy in this setting is still suboptimal and probably more than one single diagnostic procedure should be used.
Entities:
Keywords:
EUS; Gastric cancer staging; PET-CT; gastric preoperative evaluation; restaging
Authors: Seok-Ki Kim; Keon Wook Kang; Jong Seok Lee; Hark Kyun Kim; Hee Jin Chang; Jin Yi Choi; Jun Ho Lee; Keun Won Ryu; Young-Woo Kim; Jae-Moon Bae Journal: Eur J Nucl Med Mol Imaging Date: 2005-10-15 Impact factor: 9.236
Authors: Juliana M Costa; Bruno Gonçalves; Maria Miguel Gomes; Dália Fernandes; Raquel Gonçalves; João B Soares Journal: United European Gastroenterol J Date: 2018-12-07 Impact factor: 4.623
Authors: Juliana Silveira Lima de Castro; Adriane Graicer Pelosof; João Guilherme Guerra de Andrade-Cabral; Alvaro Moura Seraphim; Eloy Taglieri; Felipe Jose Fernandez Coimbra; Claudia Zitron Journal: Arq Bras Cir Dig Date: 2022-01-05
Authors: Francisco Valverde-López; Eva Julissa Ortega-Suazo; Charles Mel Wilcox; Maria Carmen Fernandez-Cano; Juan Gabriel Martínez-Cara; Eduardo Redondo-Cerezo Journal: Ann Gastroenterol Date: 2020-03-14
Authors: Victor Mihai Sacerdotianu; Bogdan Silviu Ungureanu; Sevastita Iordache; Adina Turcu-Stiolica; Antonio Facciorusso; Stefano Francesco Crinò; Adrian Saftoiu Journal: Diagnostics (Basel) Date: 2022-01-03